BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38643693)

  • 21. Development of hyaluronic acid-silica composites via in situ precipitation for improved penetration efficiency in fast-dissolving microneedle systems.
    Tay JH; Lim YH; Zheng M; Zhao Y; Tan WS; Xu C; Ramamurty U; Song J
    Acta Biomater; 2023 Dec; 172():175-187. PubMed ID: 37865280
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhancing therapeutic efficacy: sustained delivery of 5-fluorouracil (5-FU) via thiolated chitosan nanoparticles targeting CD44 in triple-negative breast cancer.
    Anjum S; Naseer F; Ahmad T; Jahan F; Qadir H; Gul R; Kousar K; Sarwar A; Shabbir A
    Sci Rep; 2024 May; 14(1):11431. PubMed ID: 38763930
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antitumor effect of hyaluronic-acid-modified chitosan nanoparticles loaded with siRNA for targeted therapy for non-small cell lung cancer.
    Zhang W; Xu W; Lan Y; He X; Liu K; Liang Y
    Int J Nanomedicine; 2019; 14():5287-5301. PubMed ID: 31406460
    [No Abstract]   [Full Text] [Related]  

  • 24. Development and Evaluation of a Novel Hyaluronic Acid and Chitosan-modified Phytosome for Co-delivery of Oxymatrine and Glycyrrhizin for Combination Therapy.
    Chen X; Yu S; Wang P; Zhao X; Sang G
    Recent Pat Anticancer Drug Discov; 2024; 19(2):154-164. PubMed ID: 38214355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intelligent and spatiotemporal drug release based on multifunctional nanoparticle-integrated dissolving microneedle system for synergetic chemo-photothermal therapy to eradicate melanoma.
    Zhao Y; Zhou Y; Yang D; Gao X; Wen T; Fu J; Wen X; Quan G; Pan X; Wu C
    Acta Biomater; 2021 Nov; 135():164-178. PubMed ID: 34530140
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Facile strategy by hyaluronic acid functional carbon dot-doxorubicin nanoparticles for CD44 targeted drug delivery and enhanced breast cancer therapy.
    Li J; Li M; Tian L; Qiu Y; Yu Q; Wang X; Guo R; He Q
    Int J Pharm; 2020 Mar; 578():119122. PubMed ID: 32035259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IgG-loaded hyaluronan-based dissolving microneedles for intradermal protein delivery.
    Mönkäre J; Reza Nejadnik M; Baccouche K; Romeijn S; Jiskoot W; Bouwstra JA
    J Control Release; 2015 Nov; 218():53-62. PubMed ID: 26437262
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyaluronic acid based microneedle array: Recent applications in drug delivery and cosmetology.
    Saha I; Rai VK
    Carbohydr Polym; 2021 Sep; 267():118168. PubMed ID: 34119141
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chitosan-hyaluronic acid nanoparticles loaded with heparin for the treatment of asthma.
    Oyarzun-Ampuero FA; Brea J; Loza MI; Torres D; Alonso MJ
    Int J Pharm; 2009 Nov; 381(2):122-9. PubMed ID: 19467809
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyaluronic acid hydrophilic surface rehabilitating curcumin nanocrystals for targeted breast cancer treatment with prolonged biodistribution.
    Ji P; Wang L; Chen Y; Wang S; Wu Z; Qi X
    Biomater Sci; 2020 Jan; 8(1):462-472. PubMed ID: 31750450
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Zein Microneedles for Localized Delivery of Chemotherapeutic Agents to Treat Breast Cancer: Drug Loading, Release Behavior, and Skin Permeation Studies.
    Bhatnagar S; Kumari P; Pattarabhiran SP; Venuganti VVK
    AAPS PharmSciTech; 2018 May; 19(4):1818-1826. PubMed ID: 29616489
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dual pH-responsive multifunctional nanoparticles for targeted treatment of breast cancer by combining immunotherapy and chemotherapy.
    Liu Y; Qiao L; Zhang S; Wan G; Chen B; Zhou P; Zhang N; Wang Y
    Acta Biomater; 2018 Jan; 66():310-324. PubMed ID: 29129789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nanosuspension-Loaded Dissolving Microneedle Patches for Enhanced Transdermal Delivery of a Highly Lipophilic Cannabidiol.
    Cheng A; Zhang S; Meng F; Xing M; Liu H; Yang G; Gao Y
    Int J Nanomedicine; 2024; 19():4061-4079. PubMed ID: 38736651
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transdermal delivery of celecoxib and α-linolenic acid from microemulsion-incorporated dissolving microneedles for enhanced osteoarthritis therapy.
    Li J; Tian X; Wang K; Jia Y; Ma F
    J Drug Target; 2023 Feb; 31(2):206-216. PubMed ID: 36093744
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Localised and sustained intradermal delivery of methotrexate using nanocrystal-loaded microneedle arrays: Potential for enhanced treatment of psoriasis.
    Tekko IA; Permana AD; Vora L; Hatahet T; McCarthy HO; Donnelly RF
    Eur J Pharm Sci; 2020 Sep; 152():105469. PubMed ID: 32679177
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyaluronic Acid Modified Curcumin-Loaded Chitosan Nanoparticles Inhibit Chondrocyte Apoptosis to Attenuate Osteoarthritis via Upregulation of Activator Protein 1 and RUNX Family Transcription Factor 2.
    Wang J; Zhang L; Zhu J; Gu J; Wang X; Tao H
    J Biomed Nanotechnol; 2022 Jan; 18(1):144-157. PubMed ID: 35180907
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ROS-Responsive Chitosan Coated Magnetic Iron Oxide Nanoparticles as Potential Vehicles for Targeted Drug Delivery in Cancer Therapy.
    Ayyanaar S; Balachandran C; Bhaskar RC; Kesavan MP; Aoki S; Raja RP; Rajesh J; Webster TJ; Rajagopal G
    Int J Nanomedicine; 2020; 15():3333-3346. PubMed ID: 32494133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chitosan/hyaluronic acid/plasmid-DNA nanoparticles encoding interleukin-1 receptor antagonist attenuate inflammation in synoviocytes induced by interleukin-1 beta.
    Deng RH; Qiu B; Zhou PH
    J Mater Sci Mater Med; 2018 Oct; 29(10):155. PubMed ID: 30276528
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Levothyroxine sodium loaded dissolving microneedle arrays for transdermal delivery.
    Ghazi RF; Al-Mayahy MH
    ADMET DMPK; 2022; 10(3):213-230. PubMed ID: 36131889
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PEGylated hyaluronic acid-coated liposome for enhanced in vivo efficacy of sorafenib via active tumor cell targeting and prolonged systemic exposure.
    Mo L; Song JG; Lee H; Zhao M; Kim HY; Lee YJ; Ko HW; Han HK
    Nanomedicine; 2018 Feb; 14(2):557-567. PubMed ID: 29248675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.